Loading…
Employees: 370
Size LEPU ScienTech Medical Technology (Shanghai) (2291.HK) is a Hong Kong Industrials company (Miscellaneous Commercial Services) with a market value of $624M, the 704th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$14.26 on 6 Nov 2026.
Performance Over six months the shares gained 25.3%, against -22.1% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue fell 4.2% over the last twelve months (peer median +4.7%); the operating margin is 42.0% (peer median 7.9%).
Valuation It trades at 11.8× forward earnings against a peer median of 14.9× (2nd cheapest of 11).
Price implies For today's price to make sense, revenue must grow about -8% a year for seven years (Req g). Recent delivered growth is +28%, so the hurdle is -36 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 18.8 points above its cost of capital (5.3% WACC).
Next results Next results expected around 26 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$571M | HK$573M | HK$511M | HK$361M | HK$288M |
| Revenue growth | — | +12% | +42% | +25% | — |
| Gross profit | HK$460M | HK$476M | HK$453M | HK$313M | HK$252M |
| EBITDA | HK$278M | HK$298M | HK$291M | HK$173M | HK$119M |
| Net income | HK$230M | HK$260M | HK$266M | HK$167M | -HK$23.0M |
| Free cash flow | HK$178M | HK$162M | HK$158M | HK$85.6M | HK$61.7M |
| Capital expenditure | HK$58.3M | HK$82.9M | HK$92.6M | HK$108M | HK$96.9M |
| Total debt | n/a | HK$1.91M | HK$3.80M | HK$2.58M | HK$3.74M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 2291.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +9.7% | -4.6% | 4th highest of 21 |
| 6-month return | +25.3% | -22.1% | 3rd highest of 21 |
| Distance from 52-week high | -28.0% | -39.5% | 7th highest of 21 |
| Revenue growth (TTM) | -4.2% | +4.7% | 5th lowest of 21 |
| Operating margin | 42.0% | 7.9% | highest of 21 |
| Forward P/E | 11.8× | 14.9× | 2nd cheapest of 11 |
| Growth the price implies (Req g, 7 yrs) | -8.4% | 5.9% | 2nd least demanding of 14 |
| Growth delivered (Del g) | +28.0% | +1.4% | 2nd highest of 14 |
| Hurdle (Req g minus delivered) | -36.4 pp | -2.9 pp | least demanding of 14 |
| ROIC minus cost of capital | +18.8 pp | -1.0 pp | 2nd highest of 19 |
| EV / EBITDA | 12.2× | 8.5× | 3rd most expensive of 9 |
| Net debt / EBITDA | -5.3× | 1.2× | 2nd least indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| LEPU ScienTech Medical Technology (Shanghai) 2291.HK | Hong Kong | $624M | +25% | -4% | 42% | 11.8× | -8.4% | +28.0% |
| Medlive Technology 2192.HK | Hong Kong | $621M | -25% | +6% | 29% | 12.6× | -0.3% | +23.8% |
| Pourin Special Welding Technology 301468.SZ | China | $621M | -40% | -4% | 5% | 66.1× | n/a | n/a |
| Strike 6196.T | Japan | $618M | +29% | +33% | 38% | 14.4× | n/a | n/a |
| Yokorei 2874.T | Japan | $617M | 0% | +1% | 5% | 15.1× | n/a | n/a |
| Framery FRAMERY.HE | Finland | $632M | 0% | +37% | 20% | 14.7× | 5.9% | +13.4% |
| China Design 603018.SS | China | $616M | -20% | -8% | 7% | 15.5× | -8.0% | -5.1% |
| FS Development Investment 300071.SZ | China | $612M | -13% | -41% | -18% | n/a | 34.6% | +1.0% |
| M-Grass Ecology And Environment (Group) 300355.SZ | China | $611M | -30% | -23% | -13% | n/a | 11.6% | +0.5% |
| BELLSYSTEM24 6183.T | Japan | $637M | -10% | +1% | 8% | 11.3× | -5.7% | +1.4% |
| Suzhou Electrical Apparatus Science Academy 300215.SZ | China | $605M | -36% | +8% | 9% | n/a | 8.1% | -4.9% |
| Intrum INTRUM.ST | Sweden | $645M | -53% | -4% | 28% | n/a | -8.9% | +0.2% |
| ChemPartner PharmaTech 300149.SZ | China | $645M | -14% | +18% | 2% | n/a | 25.6% | -5.2% |
| Plus Alpha Consulting 4071.T | Japan | $602M | +3% | +13% | 39% | 17.9× | 2.9% | +29.3% |
| China Testing & Certification International 603060.SS | China | $602M | -25% | -6% | 4% | 31.2× | 12.0% | +12.1% |
| Jiangxi First Hydraulic 301446.SZ | China | $601M | -5% | +33% | 10% | n/a | n/a | n/a |
| Winstek Semiconductor 3265.TWO | Taiwan | $593M | -24% | +15% | 20% | n/a | n/a | n/a |
| Shanghai FourSemi Semiconductor 3625.HK | Hong Kong | $592M | -69% | +3% | -16% | n/a | n/a | n/a |
| Shenzhen Longtech Smart Control 300916.SZ | China | $589M | -27% | -2% | 3% | n/a | n/a | n/a |
| Matrix Design 301365.SZ | China | $660M | -31% | +9% | 4% | n/a | 29.3% | +3.6% |
| IBEX IBEX | United States | $661M | +53% | +15% | 9% | 13.1× | 0.3% | +7.7% |